Stemline Therapeutics
Manufacturing · New York, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
750 Lexington Ave Fl 11, New York City, ...Phone Number
(646) 502-2310Website
www.stemline.comRevenue
$229.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
6
3
1
1
1
1
About Stemline Therapeutics
Stemline Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. They are based in New York City.Explore more
Stemline Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stemline Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Stemline Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Stemline Therapeutics recently announced quarterly report
Click to see if Stemline Therapeutics had a recent Job posting/layoffs
Check if Stemline Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Stemline Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Stemline Therapeutics is spiking on competitors!
Product Launch: Get notified when Stemline Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Stemline Therapeutics
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Stemline Therapeutics
Find more new buyers
Compare Similar Companies to Stemline Therapeutics
Compare insights from companies similar to Stemline Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$18.1M
501-1,000
Public
$100M
2008
RM
Rafael MarinoAffairs Operations Senior Director, Medical & Chief of Staff
Company Profile Activity
Activity Insights
Stemline Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Stemline Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Stemline Therapeutics.
Stemline Therapeutics financials insights
Gather financial insights about Stemline Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Debt
$740K
2013
Stock Offering
$33.2M
Stemline Therapeutics Tech Stack
A closer look at the technologies used by Stemline Therapeutics
See more technologies
Most Recent Scoops
Hiring Plans
Stemline Therapeutics has more open roles in Sales than it has had at any time in the past 12 months.
Hiring Plans
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
Stemline Therapeutics has more open roles in Sales than it has had at any time in the past 6 months with an increased focus that include Customer Complaint Resolution, After Sales Support, and Product Category Knowledge.
Hiring Plans
Project
Laboratory Operations, Medical Research, Clinical Operations
Stemline Therapeutics News & Media
Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant (ORSERDU®) in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
FLORENCE, Italy and NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology treatments to cancer patients, will present safety and preliminary efficacy for the elacestrant and capivasertib combination arm of the Phase 1b/2 ELEVATE study in patients with estrogen receptor-posMenarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
FLORENCE, Italy and NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology treatments to cancer patients, announced that new data related to ORSERDU® (elacestrant) and ELZONRIS® (tagraxofusp-erzs) will be presented at the 2026 American Society of Clinical Oncology (ASCO) AnElzonris (Menarini Group) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
Key market opportunities for Elzonris include pipeline expansion for rare malignancies, increased healthcare investment, and a focus on personalized oncology. Rising leukemia cases, regulatory support, and strategic partnerships further bolster growth. Localization and technological integration address tariff impacts. Key market opportunities for Elzonris include pipeline expansion for rare malignancies, increased healthcare investment, and a focus on personalized oncology. Rising leukemia casesMedidata Expands Partnership with The Menarini Group, Deploying Medidata’s Study Build AI Technology to Accelerate Global Oncology Pipeline
Fourteen-year collaboration enters a new phase as Menarini evolves its use of the Medidata Platform, combining established clinical workflows with AI to power its global oncology pipeline Fourteen-year collaboration enters a new phase as Menarini evolves its use of the Medidata Platform, combining established clinical workflows with AI to power its global oncology pipeline
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stemline Therapeutics
Sign Up For FreeTo access detailed company insights
Stemline Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. They are based in New York City.... Read More
